(Q51948539)

English

Effect of lisdexamfetamine dimesylate on parent-rated measures in children aged 6 to 12 years with attention-deficit/hyperactivity disorder: a secondary analysis.

scientific article published in September 2008

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

18 April 2018

http://europepmc.org/abstract/MED/18824828

Effect of lisdexamfetamine dimesylate on parent-rated measures in children aged 6 to 12 years with attention-deficit/hyperactivity disorder: a secondary analysis. (English)

1 reference

Europe PubMed Central

PubMed publication ID

18 April 2018

http://europepmc.org/abstract/MED/18824828

1 reference

based on heuristic

inferred from title

author name string

Frank A Lopez

1

1 reference

Europe PubMed Central

PubMed publication ID

18 April 2018

http://europepmc.org/abstract/MED/18824828

Lawrence D Ginsberg

2

1 reference

Europe PubMed Central

PubMed publication ID

18 April 2018

http://europepmc.org/abstract/MED/18824828

Valerie Arnold

3

1 reference

Europe PubMed Central

PubMed publication ID

18 April 2018

http://europepmc.org/abstract/MED/18824828

language of work or name

0 references

publication date

1 September 2008

1 reference

Europe PubMed Central

PubMed publication ID

18 April 2018

http://europepmc.org/abstract/MED/18824828

Postgraduate Medicine

1 reference

Europe PubMed Central

PubMed publication ID

18 April 2018

http://europepmc.org/abstract/MED/18824828

120

1 reference

Europe PubMed Central

PubMed publication ID

18 April 2018

http://europepmc.org/abstract/MED/18824828

3

1 reference

Europe PubMed Central

PubMed publication ID

18 April 2018

http://europepmc.org/abstract/MED/18824828

89-102

1 reference

Europe PubMed Central

PubMed publication ID

18 April 2018

http://europepmc.org/abstract/MED/18824828

Diagnosis and treatment of attention-deficit/hyperactivity disorder in children and adolescents. Council on Scientific Affairs, American Medical Association

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2008.09.1910

21 January 2018

Attention-deficit/hyperactivity disorder: diagnosis, lifespan, comorbidities, and neurobiology

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2008.09.1910

21 January 2018

Diagnosis and evaluation of adults with attention-deficit/hyperactivity disorder.

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2008.09.1910

21 January 2018

ADHD with comorbid anxiety: a review of the current literature

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2008.09.1910

21 January 2018

Influence of gender on attention deficit hyperactivity disorder in children referred to a psychiatric clinic.

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2008.09.1910

21 January 2018

Effect of comorbid symptoms of oppositional defiant disorder on responses to atomoxetine in children with ADHD: a meta-analysis of controlled clinical trial data

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2008.09.1910

21 January 2018

Effect of anxiety on cognition, behavior, and stimulant response in ADHD.

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2008.09.1910

21 January 2018

Practice Parameter for the Assessment and Treatment of Children and Adolescents With Attention-Deficit/Hyperactivity Disorder

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2008.09.1910

21 January 2018

The Texas Children's Medication Algorithm Project: revision of the algorithm for pharmacotherapy of attention-deficit/hyperactivity disorder

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2008.09.1910

21 January 2018

Clinical practice guideline: treatment of the school-aged child with attention-deficit/hyperactivity disorder

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2008.09.1910

21 January 2018

Efficacy and tolerability of lisdexamfetamine dimesylate (NRP-104) in children with attention-deficit/hyperactivity disorder: a phase III, multicenter, randomized, double-blind, forced-dose, parallel-group study

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2008.09.1910

21 January 2018

Randomized, controlled trial of oros methylphenidate once a day in children with attention-deficit/hyperactivity disorder

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2008.09.1910

21 January 2018

A double-blind, placebo-controlled trial of dexmethylphenidate hydrochloride and d,l-threo-methylphenidate hydrochloride in children with attention-deficit/hyperactivity disorder

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2008.09.1910

21 January 2018

A randomized, double-blind, placebo-controlled, parallel-group study of SLI381 (Adderall XR) in children with attention-deficit/hyperactivity disorder

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2008.09.1910

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2008.09.1910

21 January 2018

Health-related quality of life in children and adolescents who have a diagnosis of attention-deficit/hyperactivity disorder.

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2008.09.1910

21 January 2018

Efficacy and safety of modafinil film-coated tablets in children and adolescents with attention-deficit/hyperactivity disorder: results of a randomized, double-blind, placebo-controlled, flexible-dose study

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2008.09.1910

21 January 2018

Efficacy and safety of Ritalin LA, a new, once daily, extended-release dosage form of methylphenidate, in children with attention deficit hyperactivity disorder

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2008.09.1910

21 January 2018

New formulations of stimulants for attention-deficit hyperactivity disorder: therapeutic potential

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2008.09.1910

21 January 2018

ADHD comorbidity findings from the MTA study: comparing comorbid subgroups

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2008.09.1910

21 January 2018

Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition, Text Revision (DSM-IV-TR)

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2008.09.1910

21 January 2018

Attention-deficit hyperactivity disorder

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2008.09.1910

21 January 2018

How Informative Are Parent Reports of Attention-Deficit/Hyperactivity Disorder Symptoms for Assessing Outcome in Clinical Trials of Long-Acting Treatments? A Pooled Analysis of Parents' and Teachers' Reports

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2008.09.1910

21 January 2018

Identifiers

10.3810/PGM.2008.09.1910

1 reference

https://api.fatcat.wiki/v0/release/sx2tyi5oubgl3popjuqk56ncfy

30 July 2022

based on heuristic

mapped directly with Wikidata item

release_sx2tyi5oubgl3popjuqk56ncfy

1 reference

https://api.fatcat.wiki/v0/release/sx2tyi5oubgl3popjuqk56ncfy

30 July 2022

based on heuristic

mapped directly with Wikidata item

PubMed publication ID

1 reference

https://api.fatcat.wiki/v0/release/sx2tyi5oubgl3popjuqk56ncfy

30 July 2022

based on heuristic

mapped directly with Wikidata item

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q51948539&oldid=1801617960"